Tower Research Capital LLC (TRC)
Position in VVOS — Vivos Therapeutics, Inc.
CIK 1533421
NEW YORK, NY
Position in VVOS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$8,717
+$2,699 QoQ
Shares Held
7,388
+149.2% QoQ
Ownership
0.053%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2023
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VVOS Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026Tower Research Capital LLC (TRC) holds $34,298,521 across 111 Medical Devices names. VVOS ranks #86 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BSX |
Boston Scientific Corp
|
107,293 | $6,732,635 | |
| 2 | ABT |
Abbott Laboratories
|
53,293 | $5,471,591 | |
| 3 | MDT |
Medtronic plc
|
34,654 | $3,002,768 | |
| 4 | SNN |
Smith & Nephew PLC
|
93,311 | $2,965,422 | |
| 5 | GEHC |
GE HealthCare Technologies Inc.
|
39,424 | $2,806,200 | |
| 6 | SYK |
Stryker Corp
|
7,689 | $2,526,528 | |
| 7 | DXCM |
Dexcom Inc
|
32,556 | $2,044,516 | |
| 8 | PODD |
Insulet Corp
|
3,897 | $817,746 |
All Filings in VVOS
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $8,717 | 7,388 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $6,018 | 2,965 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $8,661 | 2,794 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $1,570 | 497 | Shares | Defined | 2025-08-15 | |
| 2024-12-31 | $690 | 161 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $4,340 | 1,663 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $5,068 | 2,283 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $8,350 | 1,729 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $21,371 | 1,718 | Shares | Other | 2024-02-13 | |
| No filing history on record for this holder in this stock. | ||||||